Conduit Pharmaceuticals CDT Q2 2026 earnings

FAQ

When did Conduit Pharmaceuticals report Q2 2026 earnings?

Conduit Pharmaceuticals (CDT) reported Q2 2026 earnings on August 12, 2026 before market open.

What were Conduit Pharmaceuticals's Q2 2026 revenue and EPS?

Conduit Pharmaceuticals reported revenue of $750.2M and eps of $-8.71 for Q2 2026.

How did Conduit Pharmaceuticals's Q2 2026 results compare year-over-year?

Compared to the same quarter a year prior, eps grew 80.1% from $-43.68.

Where can I find Conduit Pharmaceuticals's Q2 2026 SEC filings?

You can read the 10-Q periodic report (0001493152-26-033380) directly on SEC EDGAR. The filing index links above go to sec.gov.